About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Specific Immunotherapy for Allergic Child | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT02965612

Specific Immunotherapy for Allergic Child

The recent interest that the Specific Immunotherapy (ITS) has aroused is due to the positive potential role that could be played, in particular in the forms of allergic asthma, because this method con...

Lead sponsor: Mariella Enoc•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Alessandro Fiocchi

CONTACT

0039 06.6859.agiovanni.fiocchi@opbg.net

Chiara Mennini

CONTACT

0039 06.6859.chiara.mennini@opbg.net

Sponsors

Lead Sponsor

Mariella Enoc

Collaborators

Bial Aristegui Italia srl
OPBG Contract and Research Organization

The Investigator proposes to compare, in children with allergic rhinitis and / or allergic asthma to grasses, the pain caused by the administration of the Specific Immunotherapy (ITS) via epicutaneous with autoinjector (INJEX) pressure without needle vs. the traditional subcutaneous immunotherapy (SCIT).

Age

5 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Written informed consent from both parents / legal guardian;
•Of both sexes;
•Between the ages of 5 to 18 sensitized to grasses Awareness for grasses will be established with prick test;
•Rhinitis established according to the ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines and / or stage 1 or 2 Asthma according to GINA classification (Global Initiative for Asthma)
•It may, or not, be going on ITS with s.c. administration

Exclusion Criteria

•Children under age 5 and age\> 18 years;
•Autoimmune diseases and immunodeficiencies;
•Neoplasms;
•Severe psychological problems;
•Treatment with β-blockers;
•Poor compliance, including language training;
•Severe asthma uncontrolled by medication or irreversible airway obstruction (FEV1 less than 70% of the predicted value);
•Severe cardiovascular diseases in which may be hazardous in the administration of adrenaline

Related studies

Dietary Intervention on Atopy

NCT06547372 · Atopic Dermatitis, Atopic, and more

Evaluation of a Digital Tool to Improve Aeroallergen Immunotherapy Adherence. NavigAITme Project

NCT07419230 · Allergic Rhinitis

RECRUITINGPhase 2

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

NCT05008965 · Allergic Asthma

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

NCT06732414 · Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO"

NCT05494346 · Acute Rhinitis, Nasal Obstruction, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 17, 2016Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment36

Start dateMay 2015

Last updatedNov 17, 2016

Condition

Allergic Rhinitis Allergic Asthma Grass Allergy

Locations shown

Operating unit of Allergology

Rome

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 17, 2016Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions